SE9503117L - Ny användning av padlockprober - Google Patents

Ny användning av padlockprober

Info

Publication number
SE9503117L
SE9503117L SE9503117A SE9503117A SE9503117L SE 9503117 L SE9503117 L SE 9503117L SE 9503117 A SE9503117 A SE 9503117A SE 9503117 A SE9503117 A SE 9503117A SE 9503117 L SE9503117 L SE 9503117L
Authority
SE
Sweden
Prior art keywords
nucleic acid
padlock probes
compositions
new use
relates
Prior art date
Application number
SE9503117A
Other languages
English (en)
Swedish (sv)
Other versions
SE506908C2 (sv
SE9503117D0 (sv
Inventor
Ulf Landegren
Original Assignee
Ulf Landegren Inst F Medicinsk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulf Landegren Inst F Medicinsk filed Critical Ulf Landegren Inst F Medicinsk
Priority to SE9503117A priority Critical patent/SE506908C2/sv
Publication of SE9503117D0 publication Critical patent/SE9503117D0/xx
Priority to AU69500/96A priority patent/AU6950096A/en
Priority to EP96930482A priority patent/EP0964704B1/en
Priority to DE69619410T priority patent/DE69619410T2/de
Priority to PCT/SE1996/001119 priority patent/WO1997009069A1/en
Priority to CA002264835A priority patent/CA2264835A1/en
Publication of SE9503117L publication Critical patent/SE9503117L/
Publication of SE506908C2 publication Critical patent/SE506908C2/sv
Priority to US10/927,609 priority patent/US20050026204A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE9503117A 1995-09-08 1995-09-08 Medicinsk användning av padlockprober SE506908C2 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9503117A SE506908C2 (sv) 1995-09-08 1995-09-08 Medicinsk användning av padlockprober
AU69500/96A AU6950096A (en) 1995-09-08 1996-09-06 Methods and compositions for nucleic acid targeting
EP96930482A EP0964704B1 (en) 1995-09-08 1996-09-06 Compositions for nucleic acid targeting
DE69619410T DE69619410T2 (de) 1995-09-08 1996-09-06 Zusammensetzungen für nukleinsäure zielrichtung
PCT/SE1996/001119 WO1997009069A1 (en) 1995-09-08 1996-09-06 Methods and compositions for nucleic acid targeting
CA002264835A CA2264835A1 (en) 1995-09-08 1996-09-06 Methods and compositions for nucleic acid targeting
US10/927,609 US20050026204A1 (en) 1995-09-08 2004-08-25 Methods and compositions for nucleic acid targeting

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9503117A SE506908C2 (sv) 1995-09-08 1995-09-08 Medicinsk användning av padlockprober

Publications (3)

Publication Number Publication Date
SE9503117D0 SE9503117D0 (sv) 1995-09-08
SE9503117L true SE9503117L (sv) 1997-03-09
SE506908C2 SE506908C2 (sv) 1998-03-02

Family

ID=20399422

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9503117A SE506908C2 (sv) 1995-09-08 1995-09-08 Medicinsk användning av padlockprober

Country Status (6)

Country Link
EP (1) EP0964704B1 ( )
AU (1) AU6950096A ( )
CA (1) CA2264835A1 ( )
DE (1) DE69619410T2 ( )
SE (1) SE506908C2 ( )
WO (1) WO1997009069A1 ( )

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912124A (en) * 1996-06-14 1999-06-15 Sarnoff Corporation Padlock probe detection
JP2001514873A (ja) * 1997-08-20 2001-09-18 ソーマジェニックス インコーポレイテッド 結合特性が改善されたアンチセンスおよびアンチジーン治療薬並びにそれらの使用方法
US6977295B2 (en) 1999-04-21 2005-12-20 Invitrogen Corporation Locked nucleic acid hybrids and methods of use
FR2794755A1 (fr) * 1999-06-14 2000-12-15 Inst Nat Sante Rech Med Procede de circularisation d'oligonucleotides autour d'un acide nucleique en double brin, les structures obtenues et leurs applications
US7527945B2 (en) * 2001-10-22 2009-05-05 Nucleonics, Inc. Transfection kinetics and structural promoters
AU2012214312A1 (en) 2011-02-09 2013-08-22 Bio-Rad Laboratories, Inc. Analysis of nucleic acids
US8759036B2 (en) 2011-03-21 2014-06-24 Affymetrix, Inc. Methods for synthesizing pools of probes
DK2729580T3 (en) 2011-07-08 2015-12-14 Keygene Nv SEQUENCE BASED genotyping BASED ON OLIGONUKLEOTIDLIGERINGSASSAYS
EP3351642B1 (en) 2014-06-13 2019-09-11 Q-Linea AB Method for detecting and characterising a microorganism
GB201507026D0 (en) 2015-04-24 2015-06-10 Linea Ab Q Medical sample transportation container
GB2554767A (en) 2016-04-21 2018-04-11 Q Linea Ab Detecting and characterising a microorganism
CN112292460A (zh) 2018-06-12 2021-01-29 主基因有限公司 核酸扩增方法
CN113474466A (zh) 2019-02-21 2021-10-01 主基因有限公司 多倍体基因分型

Also Published As

Publication number Publication date
AU6950096A (en) 1997-03-27
EP0964704A1 (en) 1999-12-22
DE69619410D1 (de) 2002-03-28
DE69619410T2 (de) 2002-11-21
CA2264835A1 (en) 1997-03-13
WO1997009069A1 (en) 1997-03-13
SE506908C2 (sv) 1998-03-02
SE9503117D0 (sv) 1995-09-08
EP0964704B1 (en) 2002-02-20

Similar Documents

Publication Publication Date Title
ATE465168T1 (de) Xylo-lna analoge
SE9503117L (sv) Ny användning av padlockprober
EP1248791A4 (en) ANTI-SENSE MODULATION OF CASPASE 3 EXPRESSION
FI946201A0 (fi) Itsestabiloidut oligonukleotidit terapeuttisina aineina
ATE244506T1 (de) Oligonukleotidmodulation der expression von multiwirkstoff-resistenz -assoziiertem protein
EP1325019A4 (en) ANTISENSE MODULATION OF CLUSTERIN EXPRESSION
MXPA04000179A (es) Oligonucleotidos sinteticos de hebra doble para inhibicion especifica de expresion de gene.
EP1190099A4 (en) ANTISENSE MODULATION OF THE P13K P85 EXPRESSION
DE69403642T2 (de) 7-deazapurin modifizierte oligonukleotide
ATE239090T1 (de) Methode zum generieren von einzelsträngigen dna molekülen
EP0881914A4 ( )
WO2001032832A3 (en) Antisense inhibition of nucleolin expression
PT1053313E (pt) Oligonucleotidos ''antisense'' optimizados complementares de sequencias de dna metiltransferase
EP1250157A4 (en) ANTISENSE MODULATION OF INDUCTIBLE NITRIC OXIDE SYNTHASE EXPRESSION
EP1430072A4 (en) ANTISENSE MODULATION OF THE EXPRESSION OF THE CHOLESTERYL ESTER TRANSFER PROTEIN
WO2003023004A3 (en) Antisense modulation of fibroblast growth factor receptor 3 expression
WO2003018600A3 (en) Antisense modulation of microsomal triglyceride transfer protein expression
WO2004016754A3 (en) ANTISENSE MODULATION OF Nav1.3 EXPRESSION
DE69638166D1 (de) Integrin-gekoppelte kinase, ihre hemmstoffe und deren gebrauch für verfahren zur therapeutischen behandlung; gentherapie und bereitstellung von hemmstoffen, die als pseudosubstrate wirken
EP1248633A4 (en) ANTISENSE MODULATION OF GLYCOGENE SYNTHASE KINASE 3 BETA EXPRESSION
ATE160354T1 (de) Oligonukleotide mit anti-cytomegalovirus wirkung
EP1322658A4 (en) OLIGONUCLEOTIDE MODULATION OF HER-1 RECEPTOR EXPRESSION
BR0010396A (pt) Composições e métodos para a modificação da expressão de genes
WO2002024864A3 (en) Antisense modulation of syntaxin 4 interacting protein expression
WO2000039292A3 (de) Antisense-oligonukleotid zur hemmung der expression des adhäsionsmoleküls very late antigen 4 (vla-4) in menschlichen zellen

Legal Events

Date Code Title Description
NUG Patent has lapsed